BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI
Prominent trialists took issue with the primary endpoint, how it was powered, and what effect COVID-19 and Katsanos played.
Stay updated with breaking news from Eric Secemsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prominent trialists took issue with the primary endpoint, how it was powered, and what effect COVID-19 and Katsanos played.
IVUS-DCB is now the second trial to support intravascular imaging in peripheral interventions—what will it take to increase its use?
Experts at ISET 2024 made the case for IVUS, but given how slow uptake has been in the coronary space, the mood was a bit skeptical.
Most patients treated in US emergency departments, even those considered low risk, continue to be admitted to the hospital.
Research recently presented at an American Heart Association meeting shows high blood pressure tends to spike during the winter months.